Clinical Trial Update: Surgery Plus Chemotherapy (Doxorubicin, Vincristine and Etoposide), Mitotane, and Tariquidar to Treat Adrenocortical Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating surgery plus chemotherapy (doxorubicin, vincristine, etoposide) with mitotane and tariquidar for adrenocortical carcinoma; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenocortical Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• Mitotane (mitotane)
• Tariquidar (tariquidar)
• Vincristine (vincristine)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adrenal Cortex Neoplasms | Phase 2 | Status: COMPLETED | Results posted: 2012-09-12